UnitedHealth To Rely On NCCN Compendium For Off-Label Oncology Coverage
Executive Summary
UnitedHealth is streamlining its payment process for off-label use of oncology drugs by designating the recommendations of the National Comprehensive Cancer Network's medical compendium as its official reference
You may also be interested in...
DrugDex Endorsed As Off-Label Chemotherapy Guide For Medicare Coverage
CMS now recognizes Thomson Micromedex's DrugDex compendium as an authoritative reference for determining off-label coverage of cancer drugs under Medicare Part B, the agency announced June 10
DrugDex Endorsed As Off-Label Chemotherapy Guide For Medicare Coverage
CMS now recognizes Thomson Micromedex's DrugDex compendium as an authoritative reference for determining off-label coverage of cancer drugs under Medicare Part B, the agency announced June 10
Off-Label Dissemination Keeps FDA Stuck Between Prosecutors And Firms
As industry weighs the potential impact of FDA's guidance on good reprint practices, stakeholders are suggesting alternate policy approaches that could give companies sufficient clarity on how to conduct off-label dissemination